April 22, 2010 - The court ordered the authorization of the distribution of the net settlement fund.
October 20, 2008 - The court held a final settlement hearing, approved the settlement, entered the orders approving the plan of allocation, the motion for attorneys’ fees and expenses, and dismissed the action with prejudice.

August 8, 2008 - The court preliminarily approved the settlement.

August 6, 2008 - Parties filed a stipulation of settlement.

November 1, 2006 - The lead plaintiff filed an amended consolidated complaint.

September 11, 2006 - The lead plaintiff and lead counsel were appointed.

March 31, 2006 - The plaintiff filing the originally filed complaint on December 30, 2005, filed a notice of voluntary dismissal.

March 9, 2006 - All cases were consolidated.

March 6, 2006 - Lead plaintiff motions were filed.

January 18, 2006 - Additional investors filed complaints.

January 17, 2006 - An additional investor filed a complaint.

January 10, 2006 - Another investor filed a complaint in the U.S. District Court for the District of New Jersey on behalf of investors who purchased SFBC International Inc (NASDAQ: SFCC) common shares between August 4, 2003 and December 15, 2005. Additionally, another investor filed a complaint in the U.S. District Court for the Southern District of Florida.

December 30, 2005 - An investor in shares of SFBC International Inc (NASDAQ: SFCC) filed a lawsuit in the U.S. District Court for the Southern District of Florida against SFBC International Inc over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements made between February 17, 2004 and December 15, 2005.

The complaint alleges that, between February 17, 2004 and December 15, 2005, SFBC International Inc and certain of its officers misrepresented SFBC International Inc’s business conditions, prospects and financial results to public investors by touting SFBC International Inc’s strong revenue, earnings, and its ability to outperform competitors and obtain large contracts from drug companies, because of the large numbers of participants its facilities could handle, and its ability to quickly recruit participants for drug trials. SFBC International Inc’s financial success, however, was the result of business practices that were improper and reckless, and if discovered, would cause SFBC International Inc to lose its credibility for accurate drug testing, and thus lose customers, expose SFBC International Inc to fines and possible lawsuits from victims of faulty drugs, and face heavy regulation such that its ability to outperform competitors and quickly recruit large groups of participants could no longer be sustained.

The complaint further alleges that when the truth of SFBC International Inc’s business practices was revealed to the market beginning on November 2, 2005, through December 15, 2005, SFBC International Inc’s stock price fell from $41.49 to $15.78, a staggering 61.9% drop.